Advances in genetic research constantly open up new areas of knowledge and lead to improvements in cancer care. 2008 Public lecture series from The Research Institute of The McGill University Health Centre.
Lecture in English - Montreal General Hospital Cancer is a disease of modern times: from a longer life-span to the mutations in our environment, an increasing number of factors can trigger its onset and development. Nonetheless, advances in genetic research constantly open up new areas of knowledge and lead to improvements in cancer care. Dr. Alain Nepveu is a researcher with the Research Institute of the MUHCʼs Molecular Oncology Group. He is also Professor of Medicine, Oncology and Biochemistry in McGill Universityʼs Faculty of Medicine, where his outstanding teaching skills have earned him the title of James McGill Professor.
As a palliative care physician, Dr. Vigano has often been asked the most difficult of all questions – how long does the patient have? That is why he became deeply interested in the markers of life expectancy for cancer patients. His research focuses on prognostic studies and nutritional and functional problems of patients with advanced cancer. Dr. Antonio Vigano is an attending physician in the Palliative Care Division of the McGill University Health Centre and an associate physician in the Palliative Care Service of the Jewish General Hospital. He is also an Assistant Professor, in the Palliative Care Division of the Department of Oncology at McGill University. In 2006, Dr. Vigano developed the McGill Nutrition and Performance Laboratory (www.mnupal.mcgill.ca).
